(D) Research shows comprehensive foot 
care programs can reduce amputation rates by 
45 percent to 85 percent. 
(E) Research shows detecting and treating 
early diabetic kidney disease by lowering blood 
pressure can reduce the decline in kidney func-
tion by 30 percent to 70 percent. 
SEC. 2. MEDICARE DIABETES SCREENING COLLABORATION 
AND OUTREACH PROGRAM. 
(a) ESTABLISHMENT.—With respect to diabetes 
screening tests provided for under the Medicare Prescrip-
tion Drug, Improvement, and Modernization Act of 2003 
(Public Law 108–173) and for the purposes of reducing 
the number of undiagnosed beneficiaries with diabetes or 
prediabetes in the Medicare program, the Secretary of 
Health and Human Services (in this section referred to 
as the ‘‘Secretary’’), in collaboration with the Director of 
the Centers for Disease Control and Prevention (in this 
section referred to as the ‘‘Director)’’, shall establish an 
outreach program— 
(1) to identify existing efforts to increase 
awareness among Medicare beneficiaries and pro-
viders of the diabetes screening benefit; 
(2) to maximize economies of scale, cost effec-
tiveness, and resource allocation in increasing utili-
VerDate Aug 31 2005 
06:54 Aug 08, 2007
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H3373.IH
H3373
bajohnson on PROD1PC69 with BILLS
zation of the Medicare diabetes screening program; 
and 
(3) to build upon ongoing efforts of the private 
and nonprofit sector. 
(b) CONSULTATION.—In carrying out this section, 
the Secretary and the Director shall consult with— 
(1) various units of the Federal Government, 
including the Centers for Medicare & Medicaid Serv-
ices, the Surgeon General of the Public Health Serv-
ice, the Agency for Health Research and Quality, the 
Health Resources and Services Administration, and 
the National Institutes of Health; and 
(2) entities with an interest in diabetes, includ-
ing industry, voluntary health organization, trade as-
sociations, and professional societies. 
SEC. 3. ADVISORY GROUP REGARDING DIABETES AND 
CHRONIC 
EMPLOYEE 
WELLNESS 
INCENTIVIZATION AND DISEASE MANAGE-
MENT BEST PRACTICES. 
(a) ESTABLISHMENT.—The Secretary of Commerce 
shall establish an advisory group consisting of representa-
tives of the public and private sector. The advisory group 
shall include representatives from the Department of 
Commerce, the Department of Health and Human Serv-
ices, the Small Business Administration, and public and 
VerDate Aug 31 2005 
06:54 Aug 08, 2007
Jkt 059200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H3373.IH
H3373
bajohnson on PROD1PC69 with BILLS
private sector entities with experience in administering 
and operating employee wellness and disease management 
programs. 
(b) DUTIES.—The advisory group established under 
subsection (a) shall examine and make recommendations 
of best practices of chronic illness employee wellness 
incentivization and disease management programs in 
order to— 
(1) provide public and private sector entities 
with improved information in assessing the role of 
employee wellness incentivization and disease man-
agement programs in saving money and improving 
quality of life for patients with chronic illnesses; and 
(2) encourage the adoption of effective chronic 
illness employee wellness and disease management 
programs. 
(c) REPORT.—Not later than 1 year after the date 
of the enactment of this Act, the advisory group estab-
lished under subsection (a) shall submit to the Secretary 
of Health and Human Services, the Speaker and Minority 
Leader of the House of Representatives, and the Majority 
Leader and Minority Leader of the Senate, the results of 
the examination under subsection (b)(1). 
VerDate Aug 31 2005 
06:54 Aug 08, 2007
Jkt 059200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H3373.IH
H3373
bajohnson on PROD1PC69 with BILLS
SEC. 4. NATIONAL DIABETES REPORT CARD. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services (referred to in this section as the ‘‘Sec-
retary’’), in collaboration with the Director of the Centers 
for Disease Control and Prevention (referred to in this 
section as the ‘‘Director’’), shall prepare a national diabe-
tes report card (referred to in this section as a ‘‘Report 
Card’’) for the Nation and, to the extent possible, for each 
State on a biennial basis, that includes the statistically 
valid aggregate health outcomes related to individuals di-
agnosed with diabetes including— 
(1) HbA1c level; 
(2) LDL; 
(3) blood pressure; and 
(4) complications and comorbidities. 
(b) REPORT.—The Secretary, in collaboration with 
the Director, shall— 
(1) submit each Report Card to Congress; and 
(2) make each Report Card readily available in 
print and electronically to each State and to the 
public. 
(c) ADAPTABLE.—Each Report Card shall be able to 
be adapted by State and, where possible, local agencies 
in order to rate or report local diabetes care, costs, and 
prevalence. 
VerDate Aug 31 2005 
06:54 Aug 08, 2007
Jkt 059200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H3373.IH
H3373
bajohnson on PROD1PC69 with BILLS
(d) UPDATED REPORT.—Each Report Card that is 
prepared after the initial Report Card shall include trend 
analysis for the Nation, and, to the extent possible, for 
each State, in order to track progress in meeting estab-
lished national goals and objectives for improving diabetes 
care, costs, and prevalence (including Healthy People 
2010), and to inform policy and program development. 
SEC. 5. IMPROVEMENT OF DIABETES MORTALITY DATA 
COLLECTION. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services (in this section referred to as the ‘‘Sec-
retary’’), acting through the Director of the Centers for 
Disease Control and Prevention (in this section referred 
to as the ‘‘Director’’), and in collaboration with appro-
priate agencies, shall conduct, support, and promote the 
collection, analysis, and publication of biennial data on the 
prevalence and incidence of type 1 and 2 diabetes and of 
prediabetes. 
(b) IMPROVEMENT OF MORTALITY DATA COLLEC-
TION.— 
(1) ASSESSMENT.—The activities described in 
subsection (a) shall include an assessment of diabe-
tes as a primary or underlying cause of death and 
analysis of any under-reporting of diabetes as a pri-
mary or underlying cause of death in order to pro-
VerDate Aug 31 2005 
06:54 Aug 08, 2007
Jkt 059200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H3373.IH
H3373
bajohnson on PROD1PC69 with BILLS